• Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine Cite CITE Title : Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine Personal Author(s) : Gargano, Julia W. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109496 Gargano, Julia W. (2021). Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine. 202110(100106). Gargano, Julia W. "Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine" 202110, no. 100106 (2021) Gargano, Julia W. "Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine" vol. 202110, no. 100106, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 826.10 KB] Personal Author: Gargano, Julia W. August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 07-COVID-Gargano-508.pdf File Type: [PDF - 826.10 KB] File Type: [PDF - 826.10 KB] Rapid cycle analysis to monitor the safety of COVID-19 vaccines in near real-time within the Vaccine Safety Datalink : Myocarditis and anaphylaxis Cite CITE Title : Rapid cycle analysis to monitor the safety of COVID-19 vaccines in near real-time within the Vaccine Safety Datalink : Myocarditis and anaphylaxis Personal Author(s) : Klein, Nicola P. Corporate Authors(s) : Kaiser Permanente Vaccine Study Center.;Marshfield Clinic Research Institute. Vaccine Safety Datalink. Immunization Safety Office.; Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109493 Klein, Nicola P. (2021). Rapid cycle analysis to monitor the safety of COVID-19 vaccines in near real-time within the Vaccine Safety Datalink : Myocarditis and anaphylaxis. 202110(100103). Klein, Nicola P. "Rapid cycle analysis to monitor the safety of COVID-19 vaccines in near real-time within the Vaccine Safety Datalink : Myocarditis and anaphylaxis" 202110, no. 100103 (2021) Klein, Nicola P. "Rapid cycle analysis to monitor the safety of COVID-19 vaccines in near real-time within the Vaccine Safety Datalink : Myocarditis and anaphylaxis" vol. 202110, no. 100103, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 361.61 KB] Personal Author: Klein, Nicola P. August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 04-COVID-Klein-508.pdf File Type: [PDF - 361.61 KB] File Type: [PDF - 361.61 KB] Pfizer-BioNTech COVID-19 vaccine and myocarditis in individuals aged 16-29 years : Benefits-risk discussion Cite CITE Title : Pfizer-BioNTech COVID-19 vaccine and myocarditis in individuals aged 16-29 years : Benefits-risk discussion Personal Author(s) : Rosenblum, Hannah Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109495 Rosenblum, Hannah (2021). Pfizer-BioNTech COVID-19 vaccine and myocarditis in individuals aged 16-29 years : Benefits-risk discussion. 202110(100105). Rosenblum, Hannah "Pfizer-BioNTech COVID-19 vaccine and myocarditis in individuals aged 16-29 years : Benefits-risk discussion" 202110, no. 100105 (2021) Rosenblum, Hannah "Pfizer-BioNTech COVID-19 vaccine and myocarditis in individuals aged 16-29 years : Benefits-risk discussion" vol. 202110, no. 100105, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 2.69 MB] Personal Author: Rosenblum, Hannah August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 06-COVID-Rosenblum-508.pdf File Type: [PDF - 2.69 MB] File Type: [PDF - 2.69 MB] COVID-19 Vaccine Safety Technical (VaST) Work Group Cite CITE Title : COVID-19 Vaccine Safety Technical (VaST) Work Group Personal Author(s) : Lee, Grace M.;Hopkins, Robert H.; Corporate Authors(s) : COVID-19 Vaccine Safety Technical (VaST) Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109494 Lee, Grace M. and Hopkins, Robert H. (2021). COVID-19 Vaccine Safety Technical (VaST) Work Group. 202110(0100104). Lee, Grace M. and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group" 202110, no. 0100104 (2021) Lee, Grace M. and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group" vol. 202110, no. 0100104, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.05 MB] Personal Author: Lee, Grace M. ; Hopkins, Robert H. August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 05-COVID-Lee-508.pdf File Type: [PDF - 1.05 MB] File Type: [PDF - 1.05 MB] ACIP COVID-19 Vaccines Work Group Cite CITE Title : ACIP COVID-19 Vaccines Work Group Personal Author(s) : Daley, Matt F. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109491 Daley, Matt F. (2021). ACIP COVID-19 Vaccines Work Group. 202110(100101). Daley, Matt F. "ACIP COVID-19 Vaccines Work Group" 202110, no. 100101 (2021) Daley, Matt F. "ACIP COVID-19 Vaccines Work Group" vol. 202110, no. 100101, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 966.15 KB] Personal Author: Daley, Matt F. August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 01-COVID-Daley-508.pdf File Type: [PDF - 966.15 KB] File Type: [PDF - 966.15 KB] Framework for booster doses of COVID-19 vaccines Cite CITE Title : Framework for booster doses of COVID-19 vaccines Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109498 Oliver, Sara E. (2021). Framework for booster doses of COVID-19 vaccines. 202110(100108). Oliver, Sara E. "Framework for booster doses of COVID-19 vaccines" 202110, no. 100108 (2021) Oliver, Sara E. "Framework for booster doses of COVID-19 vaccines" vol. 202110, no. 100108, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.78 MB] Personal Author: Oliver, Sara E. August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 09-COVID-Oliver-508.pdf File Type: [PDF - 1.78 MB] File Type: [PDF - 1.78 MB] Evidence to recommendation framework : Pfizer-BioNTech COVID-19 vaccine, Comirnaty Cite CITE Title : Evidence to recommendation framework : Pfizer-BioNTech COVID-19 vaccine, Comirnaty Personal Author(s) : Dooling, Kathleen Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Aug 30 : Atlanta, GA) Published Date : August 30, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/109497 Dooling, Kathleen (2021). Evidence to recommendation framework : Pfizer-BioNTech COVID-19 vaccine, Comirnaty. 202110(100107). Dooling, Kathleen "Evidence to recommendation framework : Pfizer-BioNTech COVID-19 vaccine, Comirnaty" 202110, no. 100107 (2021) Dooling, Kathleen "Evidence to recommendation framework : Pfizer-BioNTech COVID-19 vaccine, Comirnaty" vol. 202110, no. 100107, 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 4.60 MB] Personal Author: Dooling, Kathleen August 30, 2021 | ACIP meeting COVID-19 Vaccines Description: 08-COVID-Dooling-508.pdf File Type: [PDF - 4.60 MB] File Type: [PDF - 4.60 MB]

More +